Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
08/2000
08/01/2000US6096786 Immunopotentiatory agent and physiologically acceptable salts thereof
08/01/2000US6096785 Administering glycine to the human patient for treating renal dysfunction induced by cyclosporins or ascomycins
08/01/2000US6096784 Inhibitors of oleamide hydrolase
08/01/2000US6096783 Administering to an effected eye an intraocular pressure lowering effective amount of a cyclobutane prostaglandin derivatives
08/01/2000US6096782 Administering an alanine containing peptide to the alzhiemer's patient
08/01/2000US6096781 2-phenyl-1-benzothiophene derivatives are useful for treatment of osteoporosis and hyperlipemia
08/01/2000US6096780 Antiviral compound useful for treating hiv viruses
08/01/2000US6096777 Method for inhibiting the expression of Fas
08/01/2000US6096776 Administering to the patient in need of antigen-specific immune response, an amount of green porphyrin effective to modulate the immune response to the antigen in absence of radiation absorbed by green porphyrin
08/01/2000US6096774 Energetic nitramine-linked azoles and hydroxylammonium salts as oxidizers, intiators and gas generators
08/01/2000US6096773 Inhibitor of binding of integrin to its receptors, such as (vascular cell adhesion molecule-1) and fibronectin and useful for controlling the diseases induced by binding
08/01/2000US6096772 Use of Angiotensin II type 1 receptor antagonists in the treatment of dyspeptic symptoms
08/01/2000US6096771 Isoxazole derivatives
08/01/2000US6096766 Useful in the treatment or prevention of pain, inflammation, migraine, emesis and postherpetic neuralgia
08/01/2000US6096765 Short contact treatment of acne with topical retinoids
08/01/2000US6096764 Eliminating the detrimental side-effects associated with the continuous and chronic use of gondatropin-releasing hormone factor or agonist by administering to the patient an effective amount of benzothiophene derivatives
08/01/2000US6096762 Contacting nerve cells with a neurotrophic amount of difluoroamide compound with affinity for an fk-506 binding protein for stimulating neurite grwoth in nerve cells
08/01/2000US6096760 Solid α-phenyl-2-piperidine acetate free base, its preparation and use in medicine
08/01/2000US6096759 Method for treating essential hypertension
08/01/2000US6096758 3-methylimidazopyridines
08/01/2000US6096757 Administering to the patient a farnesyl-protein transferase inhibitor 11-(4-piperidylidene)-5h-benzo(5,6)cyclohepta(1,2-b)pyridinesa nd an antineoplastic agent as antitumor/anticancer agents
08/01/2000US6096756 Administering to a patient an analgesic amount of a bimodally-acting opioid agonist and an amount of an excitatory opioid receptor antagonist effective to enhance the analgesic potency of bimodally acting opioid agonist
08/01/2000US6096755 N-substituted azabicycloalkane derivatives, their preparation and use
08/01/2000US6096754 N-3 substituted pyrimidin-4-ones with AII antagonistic activity
08/01/2000US6096753 Substituted pyrimidinone and pyridone compounds and methods of use
08/01/2000US6096749 Pyrrolopyrimidine derivatives having pharmacological activity
08/01/2000US6096748 Pyrimidine compounds useful in treating cytokine mediated diseases
08/01/2000US6096745 Imidazolone anorectic agents: III. heteroaryl derivatives
08/01/2000US6096743 1,2,3,4-tetrahydroquinoxalinedione derivative
08/01/2000US6096739 Treatment for CNS injuries
08/01/2000US6096738 Method for treatment of headache
08/01/2000US6096737 Treatment of multiple sclerosis (MS) and other demyelinating conditions using lofepramine in combination with L-phenylalanine, tyrosine or tryptophan and possibly a vitamin B12 compound
08/01/2000US6096735 Benzoheterocyclic derivatives
08/01/2000US6096734 Photosensitizers for sensitizing cells
08/01/2000US6096733 Drugs for topical application of sex steroids in the treatment of dry eye syndrome, and methods of preparation and application
08/01/2000US6096732 Steroid esters, process for their production and their pharmaceutical use
08/01/2000US6096731 Method for preventing tissue damage associated with graft-versus-host or host-versus-graft disease following transplantation
08/01/2000US6096729 Use of NK-1 receptor antagonists for treating amnestic disorders
08/01/2000US6096726 Multicomponent complex for use with substrate
08/01/2000US6096724 O(6)-alkylguanine-dna alkyltransferase (atase) enzyme inhibitors
08/01/2000US6096722 Non-steroidal treatment/prophylaxis
08/01/2000US6096721 Administering dna to a patient sublingually without gene transfer or expression to reduce viscosity of respiratory system mucous
08/01/2000US6096720 Liposomal oligonucleotide compositions
08/01/2000US6096719 Antimicrobial agents for eucaryotic microorganisms and methods of growth suppression of eucaryotic microorganisms using these agents
08/01/2000US6096714 Erythromycin derivatives, method for preparing same, and use thereof as drugs
08/01/2000US6096712 Tripeptide derivative; antiallergens, male contraceptives, antiinflammatory agents, antispasmodics, hypertensive agents
08/01/2000US6096705 Contacting cell with drug which inhibits protein kinase from phosphorylating b2 adrenergic receptor specific to an agonist compound desired to affect cell
08/01/2000US6096538 Retroviral vectors
08/01/2000US6096517 Human kidney sodium bicarbonate transporter (HNBC1A) polynucleotides
08/01/2000US6096364 Method for lowering blood glucose level by the administration of bioflavonoid
08/01/2000US6096359 Polyphenol fractions of tea, the use thereof and formulations containing them
08/01/2000US6096342 Dosage forms of risedronate
08/01/2000US6096340 Omeprazole formulation
08/01/2000US6096336 Liposomal prodrugs comprising derivatives of camptothecin and methods of treating cancer using these prodrugs
08/01/2000US6096335 Stable particulate complexes having a lamellar, rolled, and condensed structure
08/01/2000US6096329 Synergistic mixture containing fipronil
08/01/2000US6096326 Skin care compositions and use
08/01/2000US6096317 St. John's Wort and methyl donor composition and uses thereof
08/01/2000US6096313 Immunology using peptides of amino acid sequences
08/01/2000US6096301 Combined interferon/antiestrogen therapy for treatment of breast cancer
08/01/2000US6096295 Composition for causing skin lightening
08/01/2000US6096293 Applying oral composition containing 2,4-di-tert-butyl phenol to teeth
08/01/2000CA2217260C Use of vitamin d2 or vitamin d4-derivatives for the manufacture of a medicament for the treatment of secondary hyperparathyroidism
08/01/2000CA2209925C 5,6-diaryl-5,6,7,8-tetrahydronaphthalenes and their analogs as estrogen agonists/antagonists
08/01/2000CA2199845C Quinoxalinedione nmda receptor antagonists
08/01/2000CA2178760C Hiv protease inhibitors
08/01/2000CA2151618C Derivatives of benzoylecgonine, ecgonine and ecgonidine as medicines
08/01/2000CA2149150C Injectable taxol composition with improved stability
08/01/2000CA2140887C New nimesulide salt cyclodextrine inclusion complexes
08/01/2000CA2133762C Synergistic combination of a substance with gastric acid secretion inhibiting effect and an acid degradable antibiotic
08/01/2000CA2123853C Smoking suppressant and method of application thereof
08/01/2000CA2121571C Substituted phenoxy isobutyric acids and esters
08/01/2000CA2066640C Heterocyclic compounds
08/01/2000CA2026036C Sulphated glycosamino glycuronan with antithrombotic activity
08/01/2000CA2019335C Phenylalkan (en)oic acids
08/01/2000CA2018308C Anticonvulsant pyrazines
08/01/2000CA2015034C Piperazine derivatives
08/01/2000CA2014771C 5,11-dihydro-6h-dipyrido[3,2-b:2'3'-e][1,4]diazepin-6-ones and their use in the prevention or treatment of aids
08/01/2000CA2006322C Recombinant dna molecules, hosts, processes and human somatomedin carrier protein-like polypeptides
08/01/2000CA2005714C Transdermal estrogen/progestin dosage unit, system and process
07/2000
07/30/2000CA2297225A1 O-substituted hydroxycoumaranone derivatives as antitumor and antimetastatic agents
07/29/2000CA2291962A1 Glucose regulated gene
07/29/2000CA2290771A1 Azithromycin combination for emesis control in dogs
07/29/2000CA2260397A1 Method of converting rendered triglyceride oil from marine sources into bland, stable food oil
07/29/2000CA2258973A1 Glucose regulated gene
07/28/2000CA2411293A1 Novel azalides and methods of making same
07/28/2000CA2293008A1 Premixed alatrofloxacin injectable compositions
07/27/2000WO2000043553A1 Identifying, monitoring, and treating women for breast precancer or cancer
07/27/2000WO2000043525A2 Metalloproteinase-disintegrin family members: svph dnas and polypeptides
07/27/2000WO2000043517A1 Basb055 polynucleotide and polypeptide from neisseria meningitidis. uses thereof
07/27/2000WO2000043511A1 Polypeptide
07/27/2000WO2000043501A2 Ribozymes directed against the catalytic subunit of the human telomerase (htert)
07/27/2000WO2000043495A2 33 human secreted proteins
07/27/2000WO2000043419A2 Exocytosis pathway proteins and methods of use
07/27/2000WO2000043415A1 Compounds which inhibit leukocyte adhesion mediated by vla-4
07/27/2000WO2000043408A2 Steroid sulfatase inhibitors and methods for making and using the same
07/27/2000WO2000043405A1 Bis-terpyridine-platinum(ii) complexes
07/27/2000WO2000043404A1 Phosphinic pseudopeptides inhibitors of matrix metalloproteases
07/27/2000WO2000043401A1 Boron steroid mimics and pharmaceutical compositions
07/27/2000WO2000043399A1 3,6-disubstituted penam sulfone derivatives as antibacterials
1 ... 6271 6272 6273 6274 6275 6276 6277 6278 6279 6280 6281 6282 6283 6284 6285 6286 6287 6288 6289 6290 6291 ... 7860